Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyams

Showing results (751-760 of 936) with videos related to

Pageof 94
Sort By:
Journal of Occupational and Environmental Medicine|April 13, 2004
The postwar hospitalization experience of Gulf War veterans participating in U.S. health registriesTyler C Smith, Dinice L Jimenez, Besa Smith, et al.
Inflammatory Bowel Diseases|September 18, 2020
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's DiseaseRuben J Colman, Yi-Ting Tsai, Kimberly Jackson, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster DoseAvi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Gastroenterology|May 8, 2012
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in childrenJeffrey S Hyams, Anne Griffiths, James Markowitz, et al.
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Connecticut Medicine|July 1, 1996
Organ transplantation at the Hartford Transplant CenterR T Schweizer, S A Bartus, D Hull, et al.
Inflammatory Bowel Diseases|September 16, 2021
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel DiseaseJoelynn Dailey, Lina Kozhaya, Mikail Dogan, et al.
BMC Medical Informatics and Decision Making|March 11, 2025
Comparing conventional and Bayesian workflows for clinical outcome prediction modelling with an exemplar cohort study of severe COVID-19 infection incorporating clinical biomarker test resultsBrian Sullivan, Edward Barker, Louis MacGregor, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort studyOhad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Clinical Pharmacology and Therapeutics|December 23, 2020
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's DiseaseYe Xiong, Tomoyuki Mizuno, Ruben Colman, et al.
Pageof 94

Showing results (751-760 of 936) with videos related to

Sort By:
Pageof 94
Journal of Occupational and Environmental Medicine|April 13, 2004
The postwar hospitalization experience of Gulf War veterans participating in U.S. health registriesTyler C Smith, Dinice L Jimenez, Besa Smith, et al.
Inflammatory Bowel Diseases|September 18, 2020
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's DiseaseRuben J Colman, Yi-Ting Tsai, Kimberly Jackson, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster DoseAvi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Gastroenterology|May 8, 2012
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in childrenJeffrey S Hyams, Anne Griffiths, James Markowitz, et al.
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Connecticut Medicine|July 1, 1996
Organ transplantation at the Hartford Transplant CenterR T Schweizer, S A Bartus, D Hull, et al.
Inflammatory Bowel Diseases|September 16, 2021
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel DiseaseJoelynn Dailey, Lina Kozhaya, Mikail Dogan, et al.
BMC Medical Informatics and Decision Making|March 11, 2025
Comparing conventional and Bayesian workflows for clinical outcome prediction modelling with an exemplar cohort study of severe COVID-19 infection incorporating clinical biomarker test resultsBrian Sullivan, Edward Barker, Louis MacGregor, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort studyOhad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Clinical Pharmacology and Therapeutics|December 23, 2020
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's DiseaseYe Xiong, Tomoyuki Mizuno, Ruben Colman, et al.
Pageof 94